Date Filed | Type | Description |
10/12/2023 |
8-K
| Quarterly results |
09/29/2023 |
8-K
| Quarterly results |
08/09/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/04/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/31/2023 |
8-K
| Quarterly results |
07/27/2023 |
8-K
| Quarterly results |
07/24/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/13/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
07/07/2023 |
8-K/A
| Financial Statements and Exhibits Interactive Data |
07/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial State... |
06/29/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
06/12/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
06/09/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
06/08/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
06/07/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/15/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
05/05/2023 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/05/2023 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/04/2023 |
8-K
| Quarterly results |
05/04/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/04/2023 |
8-K
| Quarterly results |
05/02/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/25/2023 |
8-K
| Quarterly results |
04/06/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
04/04/2023 |
PX14A6G
| Form PX14A6G - Notice of exempt solicitation submitted by non-management: |
03/31/2023 |
8-K
| Quarterly results |
03/30/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
03/30/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
03/30/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/27/2023 |
SC 13D
| LABORATORY CORP OF AMERICA HOLDINGS reports a 9.8% stake in Enzo Biochem, Inc. |
|